JP2014501758A5 - - Google Patents

Download PDF

Info

Publication number
JP2014501758A5
JP2014501758A5 JP2013546071A JP2013546071A JP2014501758A5 JP 2014501758 A5 JP2014501758 A5 JP 2014501758A5 JP 2013546071 A JP2013546071 A JP 2013546071A JP 2013546071 A JP2013546071 A JP 2013546071A JP 2014501758 A5 JP2014501758 A5 JP 2014501758A5
Authority
JP
Japan
Prior art keywords
protein
ligand
domain
domains
asparagine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2013546071A
Other languages
English (en)
Japanese (ja)
Other versions
JP5974342B2 (ja
JP2014501758A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/SE2011/051536 external-priority patent/WO2012087230A1/en
Publication of JP2014501758A publication Critical patent/JP2014501758A/ja
Publication of JP2014501758A5 publication Critical patent/JP2014501758A5/ja
Application granted granted Critical
Publication of JP5974342B2 publication Critical patent/JP5974342B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2013546071A 2010-12-20 2011-12-19 アフィニティークロマトグラフィーマトリックス Active JP5974342B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201061424725P 2010-12-20 2010-12-20
US61/424,725 2010-12-20
PCT/SE2011/051536 WO2012087230A1 (en) 2010-12-20 2011-12-19 Affinity chromatography matrix

Publications (3)

Publication Number Publication Date
JP2014501758A JP2014501758A (ja) 2014-01-23
JP2014501758A5 true JP2014501758A5 (cg-RX-API-DMAC7.html) 2015-02-05
JP5974342B2 JP5974342B2 (ja) 2016-08-23

Family

ID=46314245

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2013546071A Active JP5974342B2 (ja) 2010-12-20 2011-12-19 アフィニティークロマトグラフィーマトリックス

Country Status (5)

Country Link
US (1) US9683013B2 (cg-RX-API-DMAC7.html)
EP (1) EP2654915B1 (cg-RX-API-DMAC7.html)
JP (1) JP5974342B2 (cg-RX-API-DMAC7.html)
CN (1) CN103269761B (cg-RX-API-DMAC7.html)
WO (1) WO2012087230A1 (cg-RX-API-DMAC7.html)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG195555A1 (en) 2008-12-24 2013-12-30 Emd Millipore Corp Caustic stable chromatography ligands
SG10201604554WA (en) 2011-06-08 2016-07-28 Emd Millipore Corp Chromatography matrices including novel staphylococcus aureus protein a based ligands
JPWO2013018880A1 (ja) * 2011-08-04 2015-03-05 独立行政法人産業技術総合研究所 プロテインgの細胞膜外ドメイン変異体のタンデム型多量体から成る新規な改変型タンパク質
US9657055B2 (en) * 2011-11-30 2017-05-23 Ge Healthcare Bioprocess R&D Ab Affinity chromatography matrix
JP6420756B2 (ja) * 2012-03-28 2018-11-07 ジーイー・ヘルスケア・バイオプロセス・アールアンドディ・アクチボラグ アフィニティークロマトグラフィーマトリックス
ES2868093T3 (es) 2012-09-17 2021-10-21 Grace W R & Co Medio y dispositivos de cromatografía
ES2887110T3 (es) 2014-01-16 2021-12-21 Grace W R & Co Medios para cromatografía de afinidad y dispositivos para cromatografía
CN104945488B (zh) * 2014-03-27 2020-02-18 迈格生物医药(上海)有限公司 一种具有免疫球蛋白结合能力的多肽
ES2929099T3 (es) 2014-05-02 2022-11-24 Grace W R & Co Material de soporte funcionalizado y métodos de fabricación y uso de material de soporte funcionalizado
US11566082B2 (en) 2014-11-17 2023-01-31 Cytiva Bioprocess R&D Ab Mutated immunoglobulin-binding polypeptides
DK3233891T3 (da) * 2014-12-17 2024-04-08 Cytiva Bioprocess R & D Ab Modificerede kappa-letkæde-bindende polypeptider
BR112017026193B1 (pt) 2015-06-05 2021-09-14 W.R. Grace & Co-Conn Adsorventes, método de produção dos adsorventes e uso dos adsorventes
GB201515339D0 (en) * 2015-08-28 2015-10-14 Ge Healthcare Bio Sciences Ab A seperation matrix and a method of seperating antibodies
JP7106187B2 (ja) 2016-05-11 2022-07-26 サイティバ・バイオプロセス・アールアンドディ・アクチボラグ 分離マトリックスを保存する方法
US10703774B2 (en) 2016-09-30 2020-07-07 Ge Healthcare Bioprocess R&D Ab Separation method
US10889615B2 (en) 2016-05-11 2021-01-12 Cytiva Bioprocess R&D Ab Mutated immunoglobulin-binding polypeptides
US10730908B2 (en) 2016-05-11 2020-08-04 Ge Healthcare Bioprocess R&D Ab Separation method
WO2017194593A1 (en) 2016-05-11 2017-11-16 Ge Healthcare Bioprocess R&D Ab Method of cleaning and/or sanitizing a separation matrix
JP7031934B2 (ja) 2016-05-11 2022-03-08 サイティバ・バイオプロセス・アールアンドディ・アクチボラグ 分離マトリックス
CN109071613A (zh) 2016-05-11 2018-12-21 通用电气医疗集团生物工艺研发股份公司 分离基质
US10654887B2 (en) 2016-05-11 2020-05-19 Ge Healthcare Bio-Process R&D Ab Separation matrix
KR101857953B1 (ko) 2016-07-06 2018-05-16 아미코젠주식회사 알칼리 내성이 증가된 변이 면역글로불린 결합 단백질
GB201615254D0 (en) 2016-09-08 2016-11-23 Ge Healthcare Bio Sciences Ab Novel Ligand and use thereof
US12448411B2 (en) 2016-09-30 2025-10-21 Cytiva Bioprocess R&D Ab Separation method
CN110799521A (zh) 2017-02-15 2020-02-14 拜奥普罗塞亚科技有限责任公司 具有温和洗脱pH的亲和色谱配体
GB201708277D0 (en) 2017-05-24 2017-07-05 Ge Healthcare A Recombinant protein
EP3875472A1 (en) * 2020-03-06 2021-09-08 Navigo Proteins Gmbh Novel immunoglobulin binding polypeptides
US20240026344A1 (en) 2020-10-13 2024-01-25 Avitide LLC Affinity ligand libraries of three-helix bundle proteins and uses thereof
GB202018588D0 (en) 2020-11-26 2021-01-13 Cytiva Bioprocess R & D Ab Separation matrix
KR20240000462A (ko) 2021-02-19 2024-01-02 아비타이드 엘엘씨 Aav2 친화성 제제
GB202113626D0 (en) 2021-09-24 2021-11-10 Cytiva Bioprocess R & D Ab FC binding polypeptides

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8505922D0 (sv) 1985-12-13 1985-12-13 Kabigen Ab Construction of an igg binding protein to facilitate downstream processing using protein engineering
US6602977B1 (en) * 1999-04-19 2003-08-05 Biovitrum Ab Receptor structures
US7709209B2 (en) 2002-03-25 2010-05-04 Ge Healthcare Bio-Sciences Ab Protein ligands
SE0200943D0 (sv) 2002-03-25 2002-03-25 Amersham Biosciences Ab Mutant protein
JP4871126B2 (ja) 2003-07-04 2012-02-08 アフィボディ・アーベー Her2に対する結合親和性を有するポリペプチド
SE0400274D0 (sv) * 2004-02-09 2004-02-09 Affibody Ab New polypeptide
DK1869071T3 (da) * 2005-03-01 2011-02-28 Affibody Ab TNF-alfa-bindende polypeptid, anvendelser deraf og fremgangsmåder, der gør brug deraf
WO2007019376A2 (en) * 2005-08-03 2007-02-15 Rq Bioscience, Inc. Methods and compositions for diagnosis of iga-and igm-mediated kidney diseases
JP5229888B2 (ja) * 2008-09-30 2013-07-03 独立行政法人産業技術総合研究所 弱酸性域での易解離性を向上したプロテインa変異型タンパク質及び抗体捕捉剤
JP2012515160A (ja) 2009-01-12 2012-07-05 ジーイー・ヘルスケア・バイオサイエンス・アクチボラグ アフィニティークロマトグラフィーマトリックス

Similar Documents

Publication Publication Date Title
JP2014501758A5 (cg-RX-API-DMAC7.html)
JP2014500311A5 (cg-RX-API-DMAC7.html)
JP2012515160A5 (cg-RX-API-DMAC7.html)
JP2014502272A5 (cg-RX-API-DMAC7.html)
Gutierrez et al. Immobilized metal‐ion affinity chromatography: status and trends
Gaberc‐Porekar et al. Potential for using histidine tags in purification of proteins at large scale
Zhao et al. Biomimetic design of affinity peptide ligands for human IgG based on protein A-IgG complex
JP2007252368A5 (cg-RX-API-DMAC7.html)
Zachariou et al. Application of immobilized metal ion chelate complexes as pseudocation exchange adsorbents for protein separation
CN105377880B (zh) 突变的免疫球蛋白结合多肽
JP2019531055A5 (cg-RX-API-DMAC7.html)
US20100069617A1 (en) Enhanced protein aggregate removal by mixed mode chromatography on hydrophobic interaction media in the presence of protein-excluded zwitterions
JP2019034963A (ja) 陽イオン交換基を用いた新規抗体精製法(Novel Antibody Purification method using Cation Exchanger)
CN103270044A (zh) 亲和色谱用载体和分离免疫球蛋白的方法
JP2016525100A5 (cg-RX-API-DMAC7.html)
JP2007532477A5 (cg-RX-API-DMAC7.html)
EP4371996A3 (en) Methods for purifying antibodies
JP2018523994A (ja) 新規な免疫グロブリン結合タンパク質およびアフィニティ精製におけるそれらの使用
Nian et al. Void exclusion of antibodies by grafted-ligand porous particle anion exchangers
Fan et al. Polydopamine meets porous membrane: a versatile platform for facile preparation of membrane adsorbers
RU2014118552A (ru) Способ выделения фукозилированных антител
CN104603153B (zh) 用于抗体纯化的载体、其制备方法及其应用
Kish et al. Peptide-based affinity adsorbents with high binding capacity for the purification of monoclonal antibodies
Scheffel et al. Optimization of a calcium-dependent Protein A-derived domain for mild antibody purification
JP2015518489A5 (cg-RX-API-DMAC7.html)